INSPIRE MEDICAL SYSTEMS INC (INSP) Forecast, Price Target & Analyst Ratings

NYSE:INSP • US4577301090

Current stock price

55.11 USD
+0.04 (+0.07%)
At close:
55.11 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSPIRE MEDICAL SYSTEMS INC (INSP).

Forecast Snapshot

Consensus Price Target

Price Target
$91.79
+ 66.55% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.25
Revenue Estimate
206.5M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$91.79
Upside
+ 66.55%
From current price of $55.11 to mean target of $91.79, Based on 25 analyst forecasts
Low
$60.60
Median
$78.03
High
$189.00

Price Target Revisions

1 Month
-3.94%
3 Months
-35.72%

Price Target Summary

25 Wall Street analysts provided a forecast for the next 12 months for INSP. The average price target is 91.79 USD. This implies a price increase of 66.55% is expected in the next year compared to the current price of 55.11.
The average price target has been revised downward by 35.72% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INSP Current Analyst RatingINSP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

INSP Historical Analyst RatingsINSP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
72.00%
INSP was analyzed by 25 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about INSP.
In the previous month the buy percentage consensus was at a similar level.
INSP was analyzed by 25 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15Truist SecuritiesMaintains Hold -> Hold
2026-04-13MizuhoMaintains Outperform -> Outperform
2026-04-10StifelMaintains Buy -> Buy
2026-04-06Evercore ISI GroupMaintains Outperform -> Outperform
2026-03-05StifelMaintains Buy -> Buy
2026-02-13Wolfe ResearchDowngrade Outperform -> Peer Perform
2026-02-12MizuhoMaintains Outperform -> Outperform
2026-02-12RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-12Wells FargoDowngrade Overweight -> Equal-Weight
2026-02-12Truist SecuritiesMaintains Hold -> Hold
2026-02-12BairdDowngrade Outperform -> Neutral
2026-02-12Piper SandlerMaintains Overweight -> Overweight
2026-02-12JefferiesMaintains Hold -> Hold
2026-01-27RBC CapitalDowngrade Outperform -> Sector Perform
2026-01-14Wells FargoMaintains Overweight -> Overweight
2026-01-08Truist SecuritiesMaintains Buy -> Buy
2025-12-23UBSMaintains Neutral -> Neutral
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-12-17RBC CapitalMaintains Outperform -> Outperform
2025-12-16JP MorganMaintains Neutral -> Neutral
2025-12-08OppenheimerUpgrade Perform -> Outperform
2025-12-08Piper SandlerMaintains Overweight -> Overweight
2025-12-04BairdMaintains Outperform -> Outperform
2025-12-02Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-26Truist SecuritiesUpgrade Hold -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.25
Revenue Estimate
206.5M
Revenue Q2Q
2.57%
EPS Q2Q
-353.91%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
-0.02%
Revenue (3 Months)
-6.00%
EPS (1 Month)
4.21%
EPS (3 Months)
-375.18%

Next Earnings Summary

INSP is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 206.50M USD.
The next earnings revenue estimate has been revised downward by 6% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
INSP revenue by date.INSP revenue by date.
624.799M
53.17%		802.804M
28.49%		911.981M
13.60%		985.08M
8.02%		1.065B
8.11%		1.174B
10.23%		1.27B
8.18%		1.391B
9.53%		1.483B
6.61%		1.656B
11.67%		1.701B
2.72%
EBITDA
YoY % growth
INSP ebitda by date.INSP ebitda by date.
-37.425M
18.18%		42.633M
213.92%		64.911M
52.26%		226.58M
249.06%		271.45M
19.80%		279.4M
2.93%		287.64M
2.95%		332.52M
15.60%		461.04M
38.65%		N/AN/A
EBIT
YoY % growth
INSP ebit by date.INSP ebit by date.
-40.271M
15.40%		36.083M
189.60%		50.954M
41.21%		63.662M
24.94%		85.535M
34.36%		112.82M
31.90%		144.16M
27.78%		190.54M
32.17%		298.71M
56.77%		479.4M
60.49%		559.98M
16.81%
Operating Margin
INSP operating margin by date.INSP operating margin by date.
-6.45%4.49%5.59%6.46%8.03%9.61%11.35%13.70%20.14%28.95%32.92%
EPS
YoY % growth
INSP eps by date.INSP eps by date.
-0.74
54.88%		1.73
333.78%		2.51
45.09%		1.99
-20.55%		2.64
32.45%		3.51
32.78%		3.94
12.26%		4.97
26.25%		5.53
11.32%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.25
-353.91%		0.29
-35.23%		0.52
52.63%		1.44
-11.06%		0.14
153.56%		0.47
62.15%		0.64
23.18%		1.19
-17.17%		0.52
282.51%		0.73
55.40%		0.75
18.08%		0.90
-24.79%
Revenue
Q2Q % growth		206.5M
2.57%		234.73M
8.13%		247.78M
10.37%		299.26M
11.22%		229.33M
11.06%		251.63M
7.20%		264M
6.55%		315.09M
5.29%		255.66M
11.48%		281.81M
11.99%		295.02M
11.75%		358.39M
13.74%
EBITDA
Q2Q % growth		24.376M
1,463.57%		51.23M
1,530.49%		52.744M
166.67%		91.625M
52.54%		100.23M
311.18%		48.28M
-5.76%		52.972M
0.43%		68.374M
-25.38%		24.286M
-75.77%		33.517M
-30.58%		35.088M
-33.76%		40.463M
-40.82%
EBIT
Q2Q % growth		-14.23M
-858.24%		7.146M
315.50%		16.16M
67.57%		51.488M
11.66%		-3.112M
78.13%		11.981M
67.66%		20.547M
27.15%		51.363M
-0.24%		17.901M
675.32%		26.775M
123.48%		28.03M
36.42%		34.048M
-33.71%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.80%
EPS Next 5 Year
14.64%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.22%
Revenue Next 5 Year
8.47%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
112.89%
EBIT Next 5 Year
62.93%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INSPIRE MEDICAL SYSTEMS INC / INSP Forecast FAQ

What is the average price target for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

25 analysts have analysed INSP and the average price target is 91.79 USD. This implies a price increase of 66.55% is expected in the next year compared to the current price of 55.11.

Can you provide the upcoming earnings date for INSPIRE MEDICAL SYSTEMS INC?

INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2026-05-04, after the market close.

What are the consensus estimates for INSP stock next earnings?

The consensus EPS estimate for the next earnings of INSPIRE MEDICAL SYSTEMS INC (INSP) is -0.25 USD and the consensus revenue estimate is 206.50M USD.

How many analysts have analysed INSPIRE MEDICAL SYSTEMS INC (INSP)?

The number of analysts covering INSPIRE MEDICAL SYSTEMS INC (INSP) is 25.